S0003732

Dolutegravir 10mg disp tab/PAC-90 No CTN


Dolutegravir 10mg dispersible scored tablets, in a bottle pack of 90, without outer carton.
Indicative Price 4.50 USD

General description:
Dolutegravir 10mg dispersible scored tablets, in a bottle pack of 90, without outer carton

Technical specifications:
Each tablet contains dolutegravir sodium equivalent to 10 mg dolutegravir

Therapeutic class:
Dolutegravir is an Integrase Inhibitor

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Component of a KIT:
This item is a component of S9901023 - IEHK2017, PEP kit (S1400651 - Dolutegravir 10mg disp tab/PAC-90 No CTN)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Related Products